Our Focus

We are focused on managing specific chronic conditions within the gastroenterology practice:

  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Non-Alcoholic Steatohepatitis (NASH)
  • Fibrosis of the Liver
  • Cirrhosis of the Liver
  • Obesity
  • Hypertension
  • Hyperlipidemia
  • Hyperglycemia
  • Irritable Bowel Syndrome
  • Inflammatory Bowel Disease
  • Ulcerative Colitis
  • Crohn’s Disease
  • Gastroesophageal reflux disease (GERD)

News

MetaPhy Launches 8 New Programs with 93 New Providers in 60 Days

In the midst of the COVID-19 pandemic, the need for telehealth-based, comprehensive chronic disease management programs has never been more important.  Six in ten Americans live with at least one chronic condition such as obesity, hypertension, and diabetes. These and other chronic diseases are the leading causes of death and disability in America and are also […]

Read More

Dietician Digest: Advice on Staying Healthy During the Coronavirus

by Christi Bowling, MS, RDN, CSSD, LD To say that we are living in interesting times is an understatement. The Coronavirus (COVID-19) pandemic has impacted almost every aspect of our lives, and for many of us, that means living in very isolated situations for the time being. During this time, social distancing is imperative to slow […]

Read More

Echosens and MetaPhy Health Collaborate to Expand Patient-Centered Care for Chronic Liver Conditions: Gastroenterology Specialists Improve Outcomes, Lower Costs & Enhance Practice Performance

WALTHAM, Mass. & NASHVILLE, Tenn.–(BUSINESS WIRE)–Echosens, a high-technology company offering the FibroScan family of products, announces its collaboration with MetaPhy Health to support turn-key, comprehensive chronic disease management services to gastroenterology practices for their patients with fatty liver disease. FibroScan, a non-invasive, rapid and painless examination to accurately detect, assess and monitor liver fat and stiffness, is a […]

Read More
Facebook
LinkedIn
Follow by Email